Hepatitis B Virus News and Research

RSS

Drinking three or more cups of coffee a day linked to reduced mortality risk in HIV-HCV patients

Patients infected by both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at specific risk of end-stage liver disease and greater risk of cardiovascular diseases and cancer.

25 Sep 2017

Routine and rapid HCV testing improves life expectancy, reduces costs for young adults

Routine and rapid hepatitis C virus testing among young adults who use injection drugs improves life expectancy and may provide a good use of limited resources, according to new research out of Boston Medical Center, in partnership with the Boston Public Health Commission.

21 Sep 2017

Scientists make significant discovery in efforts to develop vaccine against global pathogens

Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

15 Sep 2017

EHR-based prompt in primary care increases HCV screening rates among baby boomers

In a recent study, screening rates for hepatitis C virus (HCV) infection among baby boomers increased fivefold in the year following implementation of an electronic health record (EHR)-based prompt for primary care physicians.

14 Sep 2017

Intense sanitization effort as Hepatitis A outbreak in San Diego claims 16 lives

An outbreak of hepatitis A in San Diego is being investigated by the Public Health Services Division, in the County of San Diego Health and Human Services Agency. Most of the people affected with hepatitis A are the illicit drug users and homeless individuals. The spread from one person to another through fecal contamination.

14 Sep 2017

Direct-acting antiviral therapy found to be safe, effective in patients with CKD and HCV infection

A new study indicates that direct-acting antiviral therapy is safe and effective in patients with chronic kidney disease (CKD) and Hepatitis C virus (HCV) infection.

8 Sep 2017

Pork products associated with carrying hepatitis E virus in Britain

Pork products that are being sold at a leading supermarket has been associated with carrying a deadly hepatitis virus warns the researchers at the Public Health England (PHE).

20 Aug 2017

Routinely used hospital tool can predict poor outcomes in liver transplant recipients

A routinely used hospital tool can predict which liver transplant recipients are more likely to do poorly after surgery, according to a study led by Cedars-Sinai.

10 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

July 28th is marked as world hepatitis day. The world is united in elimination of viral hepatitis by 2030. The World Health Organization (WHO) has published new data from 28 countries today and shown that nearly 70% of the world hepatitis burden is borne by these countries.

27 Jul 2017

Scientists notice shift in transmission mechanism of HEV infections

Hepatitis E gets little press compared to its better-known cousins A, B, and C, but Stellenbosch University virologists say we should wake up to how transmission of this virus is changing. World Hepatitis Day is commemorated on 28 July.

27 Jul 2017

Princeton scientists test cell-culture system to aid study of HBV infections

Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections

25 Jul 2017

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

18 Jul 2017

Cancer death rates in rural America slower to decline compared to urban areas

According to the CDC, the cancer death rates nationwide have been on the decline. The reduction in these rates however is much slower in the rural areas than in other regions.

6 Jul 2017

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

Many individuals with the blood disorder thalassaemia also carry the hepatitis C virus (HCV) due to contaminated transfusions before 1990.

29 Jun 2017

UNC researchers identify how class of antiviral drugs interacts with HCV

Globally, an estimated 71 million people are living with chronic hepatitis C virus (HCV). Over decades of infection, chronic HCV infection results in progressive damage to the liver and an increased risk for end stage liver disease and liver cancer, making the virus the leading cause of liver-related deaths in the United States today.

9 Jun 2017

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

The survey results suggest a wide variation in existing national testing policy and practice when it comes to hepatitis B and C - with overall limited monitoring of testing, diagnosis, and treatment across EU/EEA Member States.

1 Jun 2017

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.

18 May 2017